Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4
- PMID: 10809780
- DOI: 10.1074/jbc.275.20.15482
Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4
Abstract
Heparan sulfate-regulated transmembrane tyrosine kinase receptor FGFR4 is the major FGFR isotype in mature hepatocytes. Fibroblast growth factor has been implicated in the definition of liver from foregut endoderm where FGFR4 is expressed and stimulation of hepatocyte DNA synthesis in vitro. Here we show that livers of mice lacking FGFR4 exhibited normal morphology and regenerated normally in response to partial hepatectomy. However, the FGFR4 (-/-) mice exhibited depleted gallbladders, an elevated bile acid pool and elevated excretion of bile acids. Cholesterol- and bile acid-controlled liver cholesterol 7alpha-hydroxylase, the limiting enzyme for bile acid synthesis, was elevated, unresponsive to dietary cholesterol, but repressed normally by dietary cholate. Expression pattern and cholate-dependent, cholesterol-induced hepatomegaly in the FGFR4 (-/-) mice suggested that activation of receptor interacting protein 140, a co-repressor of feed-forward activator liver X receptor alpha, may mediate the negative regulation of cholesterol- and bile acid-controlled liver cholesterol 7alpha-hydroxylase transcription by FGFR4 and cholate. The results demonstrate that transmembrane sensors interface with metabolite-controlled transcription networks and suggest that pericellular matrix-controlled liver FGFR4 in particular may ensure adequate cholesterol for cell structures and signal transduction.
Similar articles
-
Independent repression of bile acid synthesis and activation of c-Jun N-terminal kinase (JNK) by activated hepatocyte fibroblast growth factor receptor 4 (FGFR4) and bile acids.J Biol Chem. 2005 May 6;280(18):17707-14. doi: 10.1074/jbc.M411771200. Epub 2005 Mar 4. J Biol Chem. 2005. PMID: 15750181
-
Hepatocyte FRS2α is essential for the endocrine fibroblast growth factor to limit the amplitude of bile acid production induced by prandial activity.Curr Mol Med. 2014;14(6):703-711. doi: 10.2174/1566524014666140724095112. Curr Mol Med. 2014. PMID: 25056539 Free PMC article.
-
Increased carbon tetrachloride-induced liver injury and fibrosis in FGFR4-deficient mice.Am J Pathol. 2002 Dec;161(6):2003-10. doi: 10.1016/S0002-9440(10)64478-1. Am J Pathol. 2002. PMID: 12466116 Free PMC article.
-
Bile acids decrease hepatic paraoxonase 1 expression and plasma high-density lipoprotein levels via FXR-mediated signaling of FGFR4.Arterioscler Thromb Vasc Biol. 2006 Feb;26(2):301-6. doi: 10.1161/01.ATV.0000195793.73118.b4. Epub 2005 Nov 10. Arterioscler Thromb Vasc Biol. 2006. PMID: 16284190
-
Farnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration.Acta Pharm Sin B. 2015 Mar;5(2):93-8. doi: 10.1016/j.apsb.2015.01.005. Epub 2015 Feb 20. Acta Pharm Sin B. 2015. PMID: 26579433 Free PMC article. Review.
Cited by
-
Control of lipid metabolism by adipocyte FGFR1-mediated adipohepatic communication during hepatic stress.Nutr Metab (Lond). 2012 Oct 30;9(1):94. doi: 10.1186/1743-7075-9-94. Nutr Metab (Lond). 2012. PMID: 23106963 Free PMC article.
-
βKlotho suppresses tumor growth in hepatocellular carcinoma by regulating Akt/GSK-3β/cyclin D1 signaling pathway.PLoS One. 2013;8(1):e55615. doi: 10.1371/journal.pone.0055615. Epub 2013 Jan 30. PLoS One. 2013. PMID: 23383245 Free PMC article.
-
Klotho-beta overexpression as a novel target for suppressing proliferation and fibroblast growth factor receptor-4 signaling in hepatocellular carcinoma.Mol Cancer. 2012 Mar 23;11:14. doi: 10.1186/1476-4598-11-14. Mol Cancer. 2012. PMID: 22439738 Free PMC article.
-
First-in-Human Study of INCB062079, a Fibroblast Growth Factor Receptor 4 Inhibitor, in Patients with Advanced Solid Tumors.Target Oncol. 2023 Mar;18(2):181-193. doi: 10.1007/s11523-023-00948-8. Epub 2023 Feb 14. Target Oncol. 2023. PMID: 36787089 Free PMC article. Clinical Trial.
-
Role of fibroblast growth factor receptor 4 in cancer.Cancer Sci. 2018 Oct;109(10):3024-3031. doi: 10.1111/cas.13759. Epub 2018 Oct 3. Cancer Sci. 2018. PMID: 30070748 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous